Credit Suisse’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.38M Sell
14,581
-343
-2% -$32.5K ﹤0.01% 2083
2023
Q4
$1.38M Buy
14,924
+103
+0.7% +$7.89K ﹤0.01% 2127
2023
Q3
$948K Sell
14,821
-499
-3% -$32K ﹤0.01% 2329
2023
Q2
$947K Buy
15,320
+2,590
+20% +$154K ﹤0.01% 2413
2023
Q1
$739K Buy
12,730
+810
+7% +$46.6K ﹤0.01% 2510
2022
Q4
$709K Sell
11,920
-103
-0.9% -$6.24K ﹤0.01% 2572
2022
Q3
$761K Buy
12,023
+2,141
+22% +$149K ﹤0.01% 2513
2022
Q2
$691K Sell
9,882
-1,044
-10% -$73.1K ﹤0.01% 2636
2022
Q1
$767K Sell
10,926
-239
-2% -$16.1K ﹤0.01% 2715
2021
Q4
$758K Buy
11,165
+1,106
+11% +$76.5K ﹤0.01% 3531
2021
Q3
$704K Buy
10,059
+1,139
+13% +$82.8K ﹤0.01% 3585
2021
Q2
$624K Sell
8,920
-1,190
-12% -$86.5K ﹤0.01% 3698
2021
Q1
$787K Sell
10,110
-1,721
-15% -$122K ﹤0.01% 3473
2020
Q4
$787K Buy
11,831
+2,645
+29% +$174K ﹤0.01% 3511
2020
Q3
$572K Sell
9,186
-613
-6% -$38.4K ﹤0.01% 3310
2020
Q2
$622K Buy
9,799
+974
+11% +$65.3K ﹤0.01% 3192
2020
Q1
$632K Sell
8,825
-151
-2% -$11.9K ﹤0.01% 2976
2019
Q4
$775K Sell
8,976
-1,544
-15% -$129K ﹤0.01% 3296
2019
Q3
$861K Buy
10,520
+1,348
+15% +$112K ﹤0.01% 3111
2019
Q2
$744K Sell
9,172
-3,657
-29% -$282K ﹤0.01% 3150
2019
Q1
$973K Buy
12,829
+3,360
+35% +$267K ﹤0.01% 2913
2018
Q4
$743K Buy
9,469
+1,458
+18% +$114K ﹤0.01% 3013
2018
Q3
$604K Sell
8,011
-3,559
-31% -$262K ﹤0.01% 3187
2018
Q2
$814K Sell
11,570
-1,181
-9% -$77.3K ﹤0.01% 3162
2018
Q1
$760K Buy
12,751
+570
+5% +$34.9K ﹤0.01% 3144
2017
Q4
$742K Sell
12,181
-6,092
-33% -$389K ﹤0.01% 3208
2017
Q3
$1.14M Buy
18,273
+10,138
+125% +$653K ﹤0.01% 2998
2017
Q2
$571K Sell
8,135
-1,296
-14% -$92.6K ﹤0.01% 3064
2017
Q1
$672K Sell
9,431
-2,968
-24% -$220K ﹤0.01% 3114
2016
Q4
$940K Sell
12,399
-3,953
-24% -$274K ﹤0.01% 3068
2016
Q3
$1.08M Buy
16,352
+4,223
+35% +$274K ﹤0.01% 2896
2016
Q2
$786K Buy
12,129
+5,217
+75% +$331K ﹤0.01% 3125
2016
Q1
$431K Sell
6,912
-2,275
-25% -$142K ﹤0.01% 3332
2015
Q4
$568K Buy
+9,187
New +$595K ﹤0.01% 3276
2015
Q3
Sell
-3,717
Closed -$241K 4408
2015
Q2
$241K Sell
3,717
-242
-6% -$15.4K ﹤0.01% 4132
2015
Q1
$252K Sell
3,959
-2,003
-34% -$127K ﹤0.01% 3960
2014
Q4
$374K Buy
+5,962
New +$358K ﹤0.01% 3920
2014
Q3
Sell
-5,181
Closed -$292K 4588
2014
Q2
$292K Sell
5,181
-5,423
-51% -$295K ﹤0.01% 4125
2014
Q1
$591K Sell
10,604
-1,272
-11% -$66.7K ﹤0.01% 3579
2013
Q4
$640K Buy
11,876
+4,453
+60% +$228K ﹤0.01% 3609
2013
Q3
$351K Buy
+7,423
New +$355K ﹤0.01% 3704

Other funds holding NHC

Credit Suisse's NHC Position: Q1 2024 in Review

Credit Suisse reduced its National Healthcare (NHC) stake by 2.3% in Q1 2024, selling an estimated $32.5K and leaving 14,581 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Credit Suisse first reported a position in NHC in Q3 2013 and has held it in 41 quarters since. The position peaked at $1.38M in Q4 2023. 170 funds tracked by Wall St. Rank hold NHC as of Q1 2024.

  • Credit Suisse held 14,581 shares of National Healthcare worth $1.38M as of Q1 2024.
  • Credit Suisse sold 343 National Healthcare shares in Q1 2024, an estimated $32.5K.
  • National Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2083 holding.
  • Credit Suisse first reported a position in National Healthcare in Q3 2013 and has held it in 41 quarters since.
  • Credit Suisse's National Healthcare position peaked at $1.38M in Q4 2023.
  • 170 funds tracked by Wall St. Rank held National Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.